Huang James

Average Profitability
<0.0001%
Insider Buys Quantity
18
Insider Buys Sum
$3.24M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Huang James

The largest purchase of all time was on 2020-05-22 and amounted to 275862 shares of Windtree Therapeutics, Inc. for $2M.

Biography of Huang James

No biography is available at this moment.

2022-09-06PurchaseCASI Pharmaceuticals, Inc.
CASI
33,300
0.2621%
$4.28$142,627-44.5%
2022-08-31PurchaseCASI Pharmaceuticals, Inc.
CASI
400
0.0029%
$3.74$1,497-40.27%
2022-08-24PurchaseCASI Pharmaceuticals, Inc.
CASI
39,527
0.2821%
$3.75$148,179-41.97%
2022-08-19PurchaseCASI Pharmaceuticals, Inc.
CASI
40,000
0.294%
$3.50$139,992-36.29%
2021-10-19PurchaseWindtree Therapeutics, Inc.
WINT
director
50,000
1.9948%
$1.90$95,135-52.33%
2021-09-01PurchaseAlaunos Therapeutics, Inc.
TCRT
director
100,000
0.0445%
$1.71$171,000-36.31%
2021-03-31PurchaseWindtree Therapeutics, Inc.
WINT
150,000
7.4228%
$2.36$354,000-26.12%
2020-10-23PurchaseWindtree Therapeutics, Inc.
WINT
1,000
0.1398%
$6.67$6,666-65.44%
2020-06-04PurchaseWindtree Therapeutics, Inc.
WINT
12,000
1.8424%
$7.32$87,868-19.18%
2020-06-03PurchaseWindtree Therapeutics, Inc.
WINT
200
0.0311%
$7.42$1,484-19.68%
2020-05-22PurchaseWindtree Therapeutics, Inc.
WINT
275,862
41.9366%
$7.25$2M-21.03%
2020-02-18PurchaseWindtree Therapeutics, Inc.
WINT
400
0.0322%
$3.84$1,535-45.81%
2020-02-07PurchaseWindtree Therapeutics, Inc.
WINT
500
0.0425%
$4.05$2,025-44.16%
2020-01-17PurchaseWindtree Therapeutics, Inc.
WINT
2,000
0.1754%
$4.18$8,366-45.62%
2020-01-16PurchaseWindtree Therapeutics, Inc.
WINT
58
0.0051%
$4.20$244-35.41%
2019-12-31PurchaseWindtree Therapeutics, Inc.
WINT
15,442
1.311%
$4.05$62,525-45.57%
2019-12-30PurchaseWindtree Therapeutics, Inc.
WINT
909
0.0726%
$3.81$3,463-39.2%
2019-12-27PurchaseWindtree Therapeutics, Inc.
WINT
4,091
0.32%
$3.73$15,261-39.69%
2019-12-06PurchaseWindtree Therapeutics, Inc.
WINT
1.66M
$3.02$5M-41.67%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.